Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Screening Strategy for Systemic Sclerosis-associated Pulmonary Hypertension Incorporating Endothelial Biomarkers

NCT03459716 is registered in ClinicalTrials.gov with Louisiana State University Health Sciences Center in New Orleans as lead sponsor.

NCT NCT03459716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03459716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Screening Strategy for Systemic Sclerosis-associated Pulmonary Hypertension Incorporating Endothelial Biomarkers
Lead sponsor
Louisiana State University Health Sciences Center in New Orleans
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2018
Completion date
December 1, 2021
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, scleroderma